Aswin Anand Pai

Christian Medical College & Hospital — India

Medicine · Health Sciences

7h-index188citations44works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemoglobinopathies and Related Disorders(13), Hematopoietic Stem Cell Transplantation(11), Acute Myeloid Leukemia Research(8), Acute Lymphoblastic Leukemia research(8), Multiple Myeloma Research and Treatments(6)

Publications44 total

Role of fludarabine exposure on post-transplant outcomes in high-risk β-thalassemia patients undergoing allogeneic HCT with thiotepa/ fludarabine/ treosulfan conditioning
Blood·2025Open Access
Higher busulfan cumulative exposure predicts better thalassemia-free survival in patients with beta thalassemia undergoing HCT with busulfan-cyclophosphamide containing conditioning regimen
Blood·2025Open Access
Improving breast cancer treatments using pharmacomicrobiomics.
UNC Libraries·2025Open Access
Improving breast cancer treatments using pharmacomicrobiomics
mBio·2025· 3 citedOpen Access
Enhanced fetal hemoglobin production via dual-beneficial mutation editing of the HBG promoter in hematopoietic stem and progenitor cells for β-hemoglobinopathies
Stem Cell Research & Therapy·2024· 6 citedOpen Access
EASIXd0 Predicts Early Transplant-Related Mortality in Patients Undergoing Haploidentical Transplantation with Post-Transplant Cyclophosphamide-Mycophenolate Mofetil-Based GvHD Prophylaxis
Blood·2024
Rationalization of Anti-PD-1 Therapy Using Receptor Occupancy Data to Guide Drug Dosing - a Single Arm Phase II Trial Using Immunomodulation in Relapsed/Refractory Hodgkin Lymphoma
Blood·2024· 2 citedOpen Access
Lower Mycophenolic Acid Exposure in Patients Undergoing Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide/ Cyclosporine a-Based GvHD Prophylaxis - Need for Dose Intensification
Blood·2024· 1 cited
Precise correction of a spectrum of β-thalassemia mutations in coding and non-coding regions by base editors
Molecular Therapy — Nucleic Acids·2024· 5 citedOpen Access
Early Immune Reconstitution Is Similar in Patients with and without Acute GvHD Undergoing Haploidentical HCT with Post-Transplant Cyclophosphamide As Gvhd Prophylaxis.
Transplantation and Cellular Therapy·2024
Global Plasma Metabolomic Profiling Reveals Dysregulated Lipid Metabolism in Patients with Hepatic Sinusoidal Obstruction Syndrome - a Pilot Biomarker Study
Transplantation and Cellular Therapy·2024
T-Cell Reconstitution Can be a Predictive Biomarker for Severe Acute GvHD in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with a Treosulfan/Fludarabine Conditioning Regimen
Transplantation and Cellular Therapy·2024
Base editing of key residues in the BCL11A-XL-specific zinc finger domains derepresses fetal globin expression
Molecular Therapy·2024· 9 citedOpen Access
Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantation
PLoS ONE·2023· 1 citedOpen Access
Treosulfan Exposure Predicts Thalassemia‐Free Survival in Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Cell Transplantation
Clinical Pharmacology & Therapeutics·2023· 5 citedOpen Access
Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo
Frontiers in Pharmacology·2023· 5 citedOpen Access
Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies
Molecular Therapy — Nucleic Acids·2023· 17 citedOpen Access
Biomarkers for early complications post hematopoietic cell transplantation: Insights and challenges
Frontiers in Immunology·2023· 7 citedOpen Access
High Melphalan Systemic Exposure Is Associated with Poor Event-Free Survival after Autologous Stem Cell Transplantation (ASCT) in Patients with Multiple Myeloma
Transplantation and Cellular Therapy·2023Open Access
Glutathione S-Transferase Gene Promoter Polymorphism (GSTA1*B) Influences Haematopoietic Cell Transplantation (HCT) Outcome in Patients with β-Thalassemia Receiving Treosulfan/Fludarabine/Thiotepa Regimen
Transplantation and Cellular Therapy·2023· 1 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Poonkuzhali Balasubramanian(40), Vikram Mathews(29), Uday Kulkarni(26), Aby Abraham(26), Biju George(25), Alok Srivastava(23), Raveen Stephen Stallon Illangeswaran(17), Anu Korula(15), Anup J. Devasia(14), Ezhilpavai Mohanan(13), Saravanabhavan Thangavel(12), Sushil Selvarajan(12), John C. Panetta(12), Yukio Nakamura(11), Shaji R Velayudhan(11), Kumarasamypet M. Mohankumar(11), Balaji Balakrishnan(11), Kavitha M. Lakshmi(11), Srujan Marepally(10), Vignesh Rajendiran(8)